Cargando…

The resistance-compliance product of the pulmonary circulation varies in health and pulmonary vascular disease

Pulmonary vascular resistance (PVR) is traditionally used to describe pulmonary hemodynamic characteristics. However, it does not take into account pulmonary artery compliance (Ca) or pulsatile flow. The product of PVR and Ca is known as RC time. Previous studies assert that the PVR-Ca relationship...

Descripción completa

Detalles Bibliográficos
Autores principales: Hadinnapola, Charaka, Li, Qiuju, Su, Li, Pepke-Zaba, Joanna, Toshner, Mark
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BlackWell Publishing Ltd 2015
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4425968/
https://www.ncbi.nlm.nih.gov/pubmed/25902784
http://dx.doi.org/10.14814/phy2.12363
_version_ 1782370554194427904
author Hadinnapola, Charaka
Li, Qiuju
Su, Li
Pepke-Zaba, Joanna
Toshner, Mark
author_facet Hadinnapola, Charaka
Li, Qiuju
Su, Li
Pepke-Zaba, Joanna
Toshner, Mark
author_sort Hadinnapola, Charaka
collection PubMed
description Pulmonary vascular resistance (PVR) is traditionally used to describe pulmonary hemodynamic characteristics. However, it does not take into account pulmonary artery compliance (Ca) or pulsatile flow. The product of PVR and Ca is known as RC time. Previous studies assert that the PVR-Ca relationship is fixed and RC time is constant between health and disease states. We hypothesized that RC time was not constant in health and pulmonary vascular disease. Right heart catheterizations performed in Papworth Hospital over a 6 year period were analyzed. Subjects were divided into those with normal pulmonary hemodynamics (NPH group; n = 156) and pulmonary arterial hypertension (PAH group; n = 717). RC time and the right ventricle (RV) oscillatory power fraction were calculated. RC time for the NPH group (0.47 ± 0.13 sec) is significantly lower than the PAH group (0.56 ± 0.16 sec; P < 0.0001). The RV oscillatory power fraction is lower in the NPH group (P < 0.0001). RC time correlates inversely with the RV oscillatory power fraction in each group. We conclude, there is an inverse relationship between PVR and Ca, however, this relationship is not always fixed. Consequently, RC time is significantly lower in health compared to disease with elevated pulmonary artery pressures. PAH leads to a decrease in cardiac efficiency.
format Online
Article
Text
id pubmed-4425968
institution National Center for Biotechnology Information
language English
publishDate 2015
publisher BlackWell Publishing Ltd
record_format MEDLINE/PubMed
spelling pubmed-44259682015-05-14 The resistance-compliance product of the pulmonary circulation varies in health and pulmonary vascular disease Hadinnapola, Charaka Li, Qiuju Su, Li Pepke-Zaba, Joanna Toshner, Mark Physiol Rep Original Research Pulmonary vascular resistance (PVR) is traditionally used to describe pulmonary hemodynamic characteristics. However, it does not take into account pulmonary artery compliance (Ca) or pulsatile flow. The product of PVR and Ca is known as RC time. Previous studies assert that the PVR-Ca relationship is fixed and RC time is constant between health and disease states. We hypothesized that RC time was not constant in health and pulmonary vascular disease. Right heart catheterizations performed in Papworth Hospital over a 6 year period were analyzed. Subjects were divided into those with normal pulmonary hemodynamics (NPH group; n = 156) and pulmonary arterial hypertension (PAH group; n = 717). RC time and the right ventricle (RV) oscillatory power fraction were calculated. RC time for the NPH group (0.47 ± 0.13 sec) is significantly lower than the PAH group (0.56 ± 0.16 sec; P < 0.0001). The RV oscillatory power fraction is lower in the NPH group (P < 0.0001). RC time correlates inversely with the RV oscillatory power fraction in each group. We conclude, there is an inverse relationship between PVR and Ca, however, this relationship is not always fixed. Consequently, RC time is significantly lower in health compared to disease with elevated pulmonary artery pressures. PAH leads to a decrease in cardiac efficiency. BlackWell Publishing Ltd 2015-04-22 /pmc/articles/PMC4425968/ /pubmed/25902784 http://dx.doi.org/10.14814/phy2.12363 Text en © 2015 The Authors. Physiological Reports published by Wiley Periodicals, Inc. on behalf of the American Physiological Society and The Physiological Society. http://creativecommons.org/licenses/by/4.0/ This is an open access article under the terms of the Creative Commons Attribution License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.
spellingShingle Original Research
Hadinnapola, Charaka
Li, Qiuju
Su, Li
Pepke-Zaba, Joanna
Toshner, Mark
The resistance-compliance product of the pulmonary circulation varies in health and pulmonary vascular disease
title The resistance-compliance product of the pulmonary circulation varies in health and pulmonary vascular disease
title_full The resistance-compliance product of the pulmonary circulation varies in health and pulmonary vascular disease
title_fullStr The resistance-compliance product of the pulmonary circulation varies in health and pulmonary vascular disease
title_full_unstemmed The resistance-compliance product of the pulmonary circulation varies in health and pulmonary vascular disease
title_short The resistance-compliance product of the pulmonary circulation varies in health and pulmonary vascular disease
title_sort resistance-compliance product of the pulmonary circulation varies in health and pulmonary vascular disease
topic Original Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4425968/
https://www.ncbi.nlm.nih.gov/pubmed/25902784
http://dx.doi.org/10.14814/phy2.12363
work_keys_str_mv AT hadinnapolacharaka theresistancecomplianceproductofthepulmonarycirculationvariesinhealthandpulmonaryvasculardisease
AT liqiuju theresistancecomplianceproductofthepulmonarycirculationvariesinhealthandpulmonaryvasculardisease
AT suli theresistancecomplianceproductofthepulmonarycirculationvariesinhealthandpulmonaryvasculardisease
AT pepkezabajoanna theresistancecomplianceproductofthepulmonarycirculationvariesinhealthandpulmonaryvasculardisease
AT toshnermark theresistancecomplianceproductofthepulmonarycirculationvariesinhealthandpulmonaryvasculardisease
AT hadinnapolacharaka resistancecomplianceproductofthepulmonarycirculationvariesinhealthandpulmonaryvasculardisease
AT liqiuju resistancecomplianceproductofthepulmonarycirculationvariesinhealthandpulmonaryvasculardisease
AT suli resistancecomplianceproductofthepulmonarycirculationvariesinhealthandpulmonaryvasculardisease
AT pepkezabajoanna resistancecomplianceproductofthepulmonarycirculationvariesinhealthandpulmonaryvasculardisease
AT toshnermark resistancecomplianceproductofthepulmonarycirculationvariesinhealthandpulmonaryvasculardisease